Cancer can affect anyone, regardless of age, and it often shows no early warning signs. For many types of cancer, routine screening is still the key method for early detection, significantly lowering the chances of mortality.
Lung cancer screening guidelines can differ because this type of cancer doesn’t always display obvious symptoms and can affect both smokers and those who have never smoked.
According to Dr. Daniel J. Boffa, who heads the Commission on Cancer at the American College of Surgeons and practices as a thoracic surgeon at Yale University, screening for lung cancer is “one of the most powerful ways” to increase survival rates. He mentioned that screening can reduce the likelihood of dying from lung cancer by about 20%.
Boffa pointed out that the number of Americans who are eligible for lung cancer screening but do not take advantage of it leads to “tens of thousands of preventable deaths each year.”
He expressed hope that, within the next few years, a blood test could serve as an initial screening before confirming the presence of any issues through a CT scan, which could simplify the process and potentially help catch more lung cancer cases.
Possible Symptoms
Dr. Lary Robinson, an oncologist at Moffitt Cancer Center in Tampa, Florida, recently shared that most cases of early-stage lung cancer don’t present any symptoms. However, for those who do experience symptoms, they are often lung-related issues, such as a persistent cough, shortness of breath, or even coughing up blood.
Robinson also commented that unexplained weight loss could be indicative of various cancer types, and persistent headaches might suggest neurological issues that warrant a doctor’s visit.
Current Screening Recommendations
Current guidelines for lung cancer screening suggest that individuals aged 50 to 80, who either smoke or have a significant history of smoking (20 pack-years), should undergo annual low-dose CT scans, as per the American Cancer Society (ACS). It’s essential for individuals to discuss with their healthcare providers the reasons for screening, its process, and the potential benefits and risks involved.
They also emphasize that smokers should receive help quitting, and those with serious health conditions that may limit their lifespan shouldn’t undergo screening. Interestingly, while one in seven lung cancer cases occurs in non-smokers, there aren’t established screening guidelines for this group as of now.
Boffa mentioned that identifying individuals who might benefit from screening is an area of active research. At the moment, individuals with a family history of lung cancer, even if they don’t smoke, should consider annual screenings, particularly those in higher-risk demographics, like Asian women.
What to Expect from Screening
Advancements in lung cancer treatments have enhanced survival rates, and Boffa cautioned against viewing screenings merely as a route to receiving a terminal diagnosis. He noted that many patients carry a stigma associated with lung cancer, often perceiving it as a death sentence due to its historical reputation.
Most screenings will lead to the discovery of lung nodules or other irregularities, which are typically more linked to infections, scarring, or inflammation than to malignancies. It’s worth noting that about one-third of screenings also uncover unrelated health issues, like artery hardening or nodules elsewhere in the body.
“Over 99% of nodules are benign,” Boffa explained, highlighting the importance of discussing what such findings mean in advance. He underlined that communicating expectations is crucial since many findings do not necessarily impact life expectancy.
He’s optimistic that in the coming years, more precise guidelines will emerge for individuals at risk for lung cancer who have never smoked. The process of screening is typically quick, often just a few minutes, and doesn’t typically involve the enclosed space of an MRI machine.
Boffa reiterated that for those over 50 with a smoking background, undergoing screening for lung cancer is “one of the most powerful actions” one can take to significantly reduce their risk of a shortened lifespan due to the disease.
